ホーム › 転移性癌 › ウィスコンシン › Madison

Madison、WIにおける転移性癌の臨床試験

Madisonとその周辺地域（約30マイル以内）の拠点で、転移性癌に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？このページの上部に表示できます — 30日間 $99 →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

被験者募集中第3相

University of Wisconsin Carbone Cancer Center, Madison

18歳以上 · 全性別 · 2026/10/05更新 · NCT07562152

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

被験者募集中第2相

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

全年齢 · 全性別 · 2026/10/05更新 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

被験者募集中第1相

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

被験者募集中第1/2相

University of Wisconsin Carbone Cancer Center, Madison

12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

被験者募集中第1相

University of Wisconsin - Carbone Cancer Center, Madison

18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

被験者募集中第1相

Wisconsin Institute for Medical Research, Madison

18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

被験者募集中第1相

University of Wisconsin Hospital, Madison

18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

被験者募集中第3相

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

被験者募集中第3相

SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison

18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

被験者募集中第2相

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

18歳以上 · 全性別 · 2026/09/04更新 · NCT06311214

Biomarkers to Detect Endocrine Therapy Resistance

被験者募集中第2相

UW Carbone Cancer Center, Madison

18歳以上 · 全性別 · 2026/08/25更新 · NCT06067503

Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer

被験者募集中第1相

UW Carbone Cancer Center, Madison

18歳以上 · 全性別 · 2026/08/19更新 · NCT07197671

FOG-001 in Locally Advanced or Metastatic Solid Tumors

被験者募集中第1/2相

University of Wisconsin, Carbone Cancer Center, Madison

18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

被験者募集中第1相

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

18歳以上 · 全性別 · 2026/08/03更新 · NCT05687110